Wiro M. P. B. Menge

Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody–Drug Conjugate SYD985

Ronald C. Elgersma, Ruud G. E. Coumans, Tijl Huijbregts et al. · Molecular Pharmaceutics · 2015 · 214 citations · Full text

Molecular Biology, Duocarmycin 3B, Pharmaceutical Chemistry +16

Preclinical Profile of the HER2-Targeting ADC SYD983/SYD985: Introduction of a New Duocarmycin-Based Linker-Drug Platform

Wim H.A. Dokter, Ruud Ubink, Miranda van der Lee et al. · Molecular Cancer Therapeutics · 2014 · 156 citations · Full text

Drug Target, Immunology, Molecular Biology +18

Isoquinoline and Quinazoline Urea Analogues as Antagonists for the Human Adenosine A₃Receptor

Jacqueline E. van Muijlwijk‐Koezen, Henk Timmerman, H. van der Goot et al. · Journal of Medicinal Chemistry · 2000 · 122 citations · Full text

Synthesis of Novel Se-Substituted Selenocysteine Derivatives as Potential Kidney Selective Prodrugs of Biologically Active Selenol Compounds:  Evaluation of Kinetics of β-Elimination Reactions in Rat Renal Cytosol

Ioanna Andreadou, Wiro M. P. B. Menge, Jan N. M. Commandeur et al. · Journal of Medicinal Chemistry · 1996 · 115 citations

Selenocysteine Conjugates, Medicinal Chemistry, β-Elimination Reactions +12

Monomeric and dimeric titanatranes

Wiro M. P. B. Menge, John G. Verkade · Inorganic Chemistry · 1991 · 102 citations

Databases, Media Standards, Altmetric Attention Score +16